A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Medical iSight Establishes Neuroradiology Collaboration with NYU Langone Health

Medical iSight Corp (‘MiS’), developer of a next-generation 3D digital surgery platform, is pleased to announce a development partnership with NYU Langone Health’s Division of Neuroradiology.

The collaboration will further test MiS’ visualization, navigation, and predictive clinical insight algorithms on the image-guided removal of blood clots (thrombectomy) after a stroke, or on blood vessel repair after an aneurysm. The tool is designed to improve procedures that require that a catheter be placed in the groin or wrist, which then must be guided through blood vessels (e.g. carotid arteries, Aorta) to the damaged area.

NYU Langone has an equity interest in MiS as part of the collaboration.

Medical iSight, based in New York and London, is looking forward to working with NYU Langone’s interventional radiologists and neurosurgeons to improve preoperative planning and intraoperative navigation to speed clot removal and lessen ischemic tissue damage for stroke victims. Strokes kill 5.5 million people every year and is the second leading cause of death and the third leading cause of disability worldwide.

Platform Expansion

Medical iSight’s CEO, Justin Hall-Tipping, commented: “We are delighted to be working with NYU Langone Health and their world-class doctors to advance our groundbreaking interventional software and deliver on our vision to unite surgical digital information within a single cognitive platform, to make it universally accessible, thereby resulting in better patient outcomes.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy